MaxCyte, Inc. (MXCT) Tops Q1 EPS by 1c

MaxCyte, Inc. (NASDAQ: MXCT) reported Q1 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $9.05 million.

For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.

You May Also Be Interested In

• Uber Is Said To Be In Advanced Talks On Delivery Hero Takeover - Bloomberg
• Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
• IBM (IBM) PT Lowered to $280 at BofA Securities